Literature DB >> 14605147

Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database.

Linda K McDougal1, Christine D Steward, George E Killgore, Jasmine M Chaitram, Sigrid K McAllister, Fred C Tenover.   

Abstract

Oxacillin-resistant Staphylococcus aureus (ORSA) is a virulent pathogen responsible for both health care-associated and community onset disease. We used SmaI-digested genomic DNA separated by pulsed-field gel electrophoresis (PFGE) to characterize 957 S. aureus isolates and establish a database of PFGE patterns. In addition to PFGE patterns of U.S. strains, the database contains patterns of representative epidemic-type strains from the United Kingdom, Canada, and Australia; previously described ORSA clonal-type isolates; 13 vancomycin-intermediate S. aureus (VISA) isolates, and two high-level vancomycin-resistant, vanA-positive strains (VRSA). Among the isolates from the United States, we identified eight lineages, designated as pulsed-field types (PFTs) USA100 through USA800, seven of which included both ORSA and oxacillin-susceptible S. aureus isolates. With the exception of the PFT pairs USA100 and USA800, and USA300 and USA500, each of the PFTs had a unique multilocus sequence type and spa type motif. The USA100 PFT, previously designated as the New York/Tokyo clone, was the most common PFT in the database, representing 44% of the ORSA isolates. USA100 isolates were typically multiresistant and included all but one of the U.S. VISA strains and both VRSA isolates. Multiresistant ORSA isolates from the USA200, -500, and -600 PFTs have PFGE patterns similar to those of previously described epidemic strains from Europe and Australia. The USA300 and -400 PFTs contained community isolates resistant only to beta-lactam drugs and erythromycin. Noticeably absent from the U.S. database were isolates with the previously described Brazilian and EMRSA15 PFGE patterns. These data suggest that there are a limited number of ORSA genotypes present in the United States.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14605147      PMCID: PMC262524          DOI: 10.1128/JCM.41.11.5113-5120.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  68 in total

1.  Staphylococcus aureus with reduced susceptibility to vancomycin--United States, 1997.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1997-08-22       Impact factor: 17.586

2.  Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms.

Authors:  M C Maiden; J A Bygraves; E Feil; G Morelli; J E Russell; R Urwin; Q Zhang; J Zhou; K Zurth; D A Caugant; I M Feavers; M Achtman; B G Spratt
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

3.  Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.

Authors:  K Hiramatsu; H Hanaki; T Ino; K Yabuta; T Oguri; F C Tenover
Journal:  J Antimicrob Chemother       Date:  1997-07       Impact factor: 5.790

4.  The evolution of pandemic clones of methicillin-resistant Staphylococcus aureus: identification of two ancestral genetic backgrounds and the associated mec elements.

Authors:  D C Oliveira; A Tomasz; H de Lencastre
Journal:  Microb Drug Resist       Date:  2001       Impact factor: 3.431

5.  Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients.

Authors:  Yves Gillet; Bertrand Issartel; Philippe Vanhems; Jean-Christophe Fournet; Gerard Lina; Michèle Bes; François Vandenesch; Yves Piémont; Nicole Brousse; Daniel Floret; Jerome Etienne
Journal:  Lancet       Date:  2002-03-02       Impact factor: 79.321

6.  Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk.

Authors:  B C Herold; L C Immergluck; M C Maranan; D S Lauderdale; R E Gaskin; S Boyle-Vavra; C D Leitch; R S Daum
Journal:  JAMA       Date:  1998-02-25       Impact factor: 56.272

7.  Population-based community prevalence of methicillin-resistant Staphylococcus aureus in the urban poor of San Francisco.

Authors:  Edwin D Charlebois; David R Bangsberg; Nicholas J Moss; Matthew R Moore; Andrew R Moss; Henry F Chambers; Françoise Perdreau-Remington
Journal:  Clin Infect Dis       Date:  2002-01-02       Impact factor: 9.079

Review 8.  Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications.

Authors:  Roland Leclercq
Journal:  Clin Infect Dis       Date:  2002-01-11       Impact factor: 9.079

9.  Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides.

Authors:  F C Tenover; M V Lancaster; B C Hill; C D Steward; S A Stocker; G A Hancock; C M O'Hara; S K McAllister; N C Clark; K Hiramatsu
Journal:  J Clin Microbiol       Date:  1998-04       Impact factor: 5.948

10.  An outbreak of community-acquired foodborne illness caused by methicillin-resistant Staphylococcus aureus.

Authors:  Timothy F Jones; Molly E Kellum; Susan S Porter; Michael Bell; William Schaffner
Journal:  Emerg Infect Dis       Date:  2002-01       Impact factor: 6.883

View more
  566 in total

1.  Prevalence and risk factors for MRSA nasal colonization among persons experiencing homelessness in Boston, MA.

Authors:  Jessica H Leibler; Casey León; Lena J P Cardoso; Jennifer C Morris; Nancy S Miller; Daniel D Nguyen; Jessie M Gaeta
Journal:  J Med Microbiol       Date:  2017-08       Impact factor: 2.472

Review 2.  Colonization, pathogenicity, host susceptibility, and therapeutics for Staphylococcus aureus: what is the clinical relevance?

Authors:  Steven Y C Tong; Luke F Chen; Vance G Fowler
Journal:  Semin Immunopathol       Date:  2011-12-11       Impact factor: 9.623

3.  Surveillance of methicillin-resistant Staphylococcus aureus in a pediatric hospital in Mexico City during a 7-year period (1997 to 2003): clonal evolution and impact of infection control.

Authors:  M E Velazquez-Meza; M Aires de Sousa; G Echaniz-Aviles; F Solórzano-Santos; G Miranda-Novales; J Silva-Sanchez; H de Lencastre
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

4.  Antimicrobial activity of the investigational pleuromutilin compound BC-3781 tested against Gram-positive organisms commonly associated with acute bacterial skin and skin structure infections.

Authors:  Helio S Sader; Douglas J Biedenbach; Susanne Paukner; Zrinka Ivezic-Schoenfeld; Ronald N Jones
Journal:  Antimicrob Agents Chemother       Date:  2012-01-09       Impact factor: 5.191

5.  Relationship between susceptibility to daptomycin in vitro and activity in vivo in a rabbit model of aortic valve endocarditis.

Authors:  H F Chambers; L Basuino; B A Diep; J Steenbergen; S Zhang; P Tattevin; J Alder
Journal:  Antimicrob Agents Chemother       Date:  2009-01-26       Impact factor: 5.191

6.  Characterisation of a Staphylococcus aureus strain with progressive loss of susceptibility to vancomycin and daptomycin during therapy.

Authors:  Fred C Tenover; Scott W Sinner; Robert E Segal; Vanthida Huang; Shandline S Alexandre; John E McGowan; Melvin P Weinstein
Journal:  Int J Antimicrob Agents       Date:  2009-02-23       Impact factor: 5.283

7.  Colonization sites of USA300 methicillin-resistant Staphylococcus aureus in residents of extended care facilities.

Authors:  Simone M Shurland; O Colin Stine; Richard A Venezia; Jennifer K Johnson; Min Zhan; Jon P Furuno; Ram R Miller; Tamara Johnson; Mary-Claire Roghmann
Journal:  Infect Control Hosp Epidemiol       Date:  2009-04       Impact factor: 3.254

8.  Staphylococcus aureus biofilm metabolism and the influence of arginine on polysaccharide intercellular adhesin synthesis, biofilm formation, and pathogenesis.

Authors:  Yefei Zhu; Elizabeth C Weiss; Michael Otto; Paul D Fey; Mark S Smeltzer; Greg A Somerville
Journal:  Infect Immun       Date:  2007-06-18       Impact factor: 3.441

9.  Community-associated methicillin-resistant Staphylococcus aureus colonization burden in HIV-infected patients.

Authors:  Kyle J Popovich; Bala Hota; Alla Aroutcheva; Lisa Kurien; Janki Patel; Rosie Lyles-Banks; Amanda E Grasso; Andrej Spec; Kathleen G Beavis; Mary K Hayden; Robert A Weinstein
Journal:  Clin Infect Dis       Date:  2013-01-16       Impact factor: 9.079

10.  Environmental Panels as a Proxy for Nursing Facility Patients With Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococcus Colonization.

Authors:  Marco Cassone; Julia Mantey; Mary Beth Perri; Kristen Gibson; Bonnie Lansing; Sara McNamara; Payal K Patel; Vincent C C Cheng; Maroya S Walters; Nimalie D Stone; Marcus J Zervos; Lona Mody
Journal:  Clin Infect Dis       Date:  2018-08-31       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.